| Literature DB >> 27540422 |
Dong-Yeon Kim1, Jung-Joon Min1.
Abstract
Despite substantial advances in the diagnosis of cardiovascular disease, (18)F-labeled positron emission tomography (PET) radiopharmaceuticals remain necessary to diagnose heart disease because clinical use of current PET tracers is limited by their short half-life. Lipophilic cations such as phosphonium salts penetrate the mitochondrial membranes and accumulate in mitochondria of cardiomyocytes in response to negative inner-transmembrane potentials. Radiolabeled tetraphenylphosphonium cation derivatives have been developed as myocardial imaging agents for PET. In this review, a general overview of these radiotracers, including their radiosynthesis, in vivo characterization, and evaluation is provided and clinical perspectives are discussed.Entities:
Keywords: 18F-Fluoroalkylphosphonium cations; Mitochondrial voltage sensors; Myocardial imaging agents; Positron emission tomography; Tetraphenylphosphonium cation derivatives
Year: 2016 PMID: 27540422 PMCID: PMC4977252 DOI: 10.1007/s13139-016-0397-x
Source DB: PubMed Journal: Nucl Med Mol Imaging ISSN: 1869-3474